MeiraGTx Holdings plc
Last updated September 27, 2026
Organization details
- Legal name
- MeiraGTx Holdings plc
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MGTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001735438
- EIN
- 98-1448305
Board of directors
-
Alan Sebulsky · DirectorSince 2026
-
Alexandria Forbes · Director · PRESIDENT & CEOSince 2023
-
Debra Yu · DirectorSince 2023
-
Ellen Hukkelhoven · DirectorSince 2023
- Since 2023
-
Keith R. Harris · DirectorSince 2023
-
Martin Indyk · DirectorSince 2023
-
Neil Mendoza · DirectorSince 2023
-
Nicole Seligman · DirectorSince 2023
-
Thomas E. Shenk · DirectorSince 2023
Chief executives
Alexandria Forbes
· PRESIDENT & CEO
Dates unknown
Director election results
Annual meeting of June 8, 2023. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.1%
-
98.4%
-
99.6%
Board connections
5 of this board's directors also sit on 12 other boards.
- via Joseph Edelman
- via Debra Yu
- via Joseph Edelman
- via Joseph Edelman
- via Nicole Seligman
- via Joseph Edelman
- via Joseph Edelman
- via Joseph Edelman
- via Alan Sebulsky
- via Nicole Seligman
- via Joseph Edelman
- via Keith R. Harris
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $4,439,942
- 10 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Alexandria Forbes Director, Officer (PRESIDENT & CEO) | Open-market sale | −62,000 | $13.86 | $859,320 |
| Jul 21, 2026 | Giroux Richard Officer (CFO & COO) | Open-market sale | −56,000 | $12.51 | $700,560 |
| Jul 7, 2026 | Naylor Stuart Officer (CHIEF SCI OFCR, OPHTHALMOLOGY) | Open-market sale | −2,547 | $13.86 | $35,301 |
| Jul 7, 2026 | Naylor Stuart Officer (CHIEF SCI OFCR, OPHTHALMOLOGY) | Open-market sale | −25,112 | $14.90 | $374,169 |
| Jun 10, 2026 | Keith R. Harris Director | Option exercise | +75,000 | — | — |
| May 27, 2026 | Giroux Richard Officer (CFO & COO) | Gift | −7,000 | — | — |
| May 19, 2026 | Alexandria Forbes Director, Officer (PRESIDENT & CEO) | Open-market sale | −62,000 | $9.17 | $568,540 |
| Apr 21, 2026 | Giroux Richard Officer (CFO & COO) | Open-market sale | −56,000 | $10.22 | $572,320 |
| Apr 17, 2026 | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Director, 10% owner | Grant or award | +555,555 | $9.00 | $4,999,995 |
| Apr 7, 2026 | Naylor Stuart Officer (CHIEF DEV. OFFICER) | Open-market sale | −27,661 | $9.36 | $258,907 |
| Mar 24, 2026 | Alexandria Forbes Director, Officer (PRESIDENT & CEO) | Open-market sale | −62,000 | $7.41 | $459,420 |
| Feb 21, 2026 | Zeldin Robert K Officer (CHIEF MEDICAL OFFICER) | Option exercise | +7,500 | — | — |
| Feb 21, 2026 | Wollin Robert J Officer (GENERAL COUNSEL AND SECRETARY) | Option exercise | +11,250 | — | — |
| Feb 21, 2026 | Naylor Stuart Officer (CHIEF DEV. OFFICER) | Option exercise | +25,000 | — | — |
| Feb 21, 2026 | Giroux Richard Officer (CFO & COO) | Option exercise | +60,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.